Biomind Labs Valuation

BMNDF Stock  USD 0.11  0.00  0.00%   
Biomind Labs seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Biomind Labs from analyzing the firm fundamentals such as Current Valuation of 39.1 M, return on equity of -5.72, and Shares Owned By Insiders of 90.07 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.11
Please note that Biomind Labs' price fluctuation is out of control at this time. Calculation of the real value of Biomind Labs is based on 3 months time horizon. Increasing Biomind Labs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biomind pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Biomind Labs. Since Biomind Labs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biomind Pink Sheet. However, Biomind Labs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.11 Real  0.0865 Hype  0.11
The real value of Biomind Pink Sheet, also known as its intrinsic value, is the underlying worth of Biomind Labs Company, which is reflected in its stock price. It is based on Biomind Labs' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Biomind Labs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.09
Real Value
55.59
Upside
Estimating the potential upside or downside of Biomind Labs helps investors to forecast how Biomind pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomind Labs more accurately as focusing exclusively on Biomind Labs' fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.010.1155.61
Details

About Biomind Labs Valuation

The pink sheet valuation mechanism determines Biomind Labs' current worth on a weekly basis. Our valuation model uses a comparative analysis of Biomind Labs. We calculate exposure to Biomind Labs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biomind Labs's related companies.
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammation, and BMND07 for treating major depressive disorder. Biomind Labs is traded on OTC Exchange in the United States.

8 Steps to conduct Biomind Labs' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biomind Labs' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biomind Labs' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Biomind Labs' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Biomind Labs' revenue streams: Identify Biomind Labs' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Biomind Labs' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Biomind Labs' growth potential: Evaluate Biomind Labs' management, business model, and growth potential.
  • Determine Biomind Labs' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biomind Labs' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Biomind Labs Growth Indicators

Investing in growth stocks can be very risky. If the company such as Biomind Labs does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding74.8 M
Retained Earnings-10.4 M

Complementary Tools for Biomind Pink Sheet analysis

When running Biomind Labs' price analysis, check to measure Biomind Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomind Labs is operating at the current time. Most of Biomind Labs' value examination focuses on studying past and present price action to predict the probability of Biomind Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomind Labs' price. Additionally, you may evaluate how the addition of Biomind Labs to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk